1 diotherapy in locally advanced squamous cell cancer of the head and neck (LASCCHN).

2 isplatin, and fluorouracil for squamous cell cancer of the head and neck (SCCHN) and to determine the

3  chemotherapy agents active in squamous cell cancer of the head and neck could increase treatment eff

4 rall survival of patients with squamous cell cancer of the head and neck has not significantly improv

5    Maxillary sinus carcinoma (MSC) is a rare cancer of the head and neck region.

6 cil in patients with recurrent squamous cell cancer of the head and neck.

7 ntly lower incidence was found among men for cancers of the head and neck (SIR = 0.78), lung (SIR = 0

8 proach to measure DNA methylation changes in cancers of the head and neck and to compare these change

9                                              Cancers of the head and neck that arise from habitual ex

10 n cancer, germ cell tumors, leiomyosarcomas, cancers of the head and neck, conjunctival cancer, multi

11 cancers and is also strongly associated with cancers of the head and neck, esophagus and urinary blad

12                                              Cancers of the head and neck, prostate, liver, and bladd

13                 The laparoscopic findings in cancer of the head of the pancreas had an important infl

14                             In patients with cancer of the head of the pancreas, metastatic disease o

15 Laparoscopic ultrasonography was valuable in cancer of the head of the pancreas.